1.
Voen Med Zh
; 331(12): 4-8, 2010 Dec.
Article
in Russian
| MEDLINE
| ID: mdl-21488354
ABSTRACT
By the example of rheumatoid arthritis was considered the methods of economic assessment of advisability of modern biological medication usage in military medicine. The usage of these medications leads to quick clinical response, decrease of the additional medication intake, decrease of the average duration of treatment, "move aside" time of permanent disablement. Modern active therapy can increase the effectiveness of treatment; improve the quality of life, decrease the average duration of hospital stay, following treatment expense and welfare payment for this category of ill.
Subject(s)
Antibodies, Monoclonal/economics , Drug Costs , Military Medicine/economics , Adalimumab , Antibodies, Monoclonal/administration & dosage , Antibodies, Monoclonal/therapeutic use , Antibodies, Monoclonal, Humanized , Antibodies, Monoclonal, Murine-Derived/administration & dosage , Antibodies, Monoclonal, Murine-Derived/economics , Antibodies, Monoclonal, Murine-Derived/therapeutic use , Arthritis, Rheumatoid/drug therapy , Arthritis, Rheumatoid/economics , Cost-Benefit Analysis , Humans , Infliximab , Military Personnel , Rituximab , Russia
2.
Voen Med Zh
; (7): 53, 1986 Jul.
Article
in Russian
| MEDLINE
| ID: mdl-3750921